Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Better care for Fabry

Better care for Fabry

Every Moment Matters on the Fabry Journey

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Educational video on "Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options" outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

EVOLUTION: RWE from Saudi Arabia

EVOLUTION: RWE from Saudi Arabia

Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.

How To Diagnose LSDs?

How To Diagnose LSDs?

Learn more about early diagnosis of lysosomal storage disorders: Fabry disease, Pompe Disease, Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD, also known as Niemann-Pick Type A/B), mucopolysaccharidoses (MPSs).

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia

Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry

Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry

Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study

Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice